Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1091]
News [2721]
Articles [182]
Editorials [9]
Conferences [110]
elearning [25]

Mechanisms of action and robotics in mCRPC

Dr Anthony Ng Chi-Fai - University of Hong Kong, Hong Kong, China
Mechanisms of action and robotics in mCRPC ( Dr Anthony Ng Chi-Fai - University of Hong Kong, Hong Kong, China )
21 Mar 2014

mCRPC management in Taiwan - expert interview

Prof Paul de Souza and Dr Wayne Yen-Hwa Chang
mCRPC management in Taiwan - expert interview ( Prof Paul de Souza and Dr Wayne Yen-Hwa Chang )
21 Mar 2014

Cost constraints affect treatment decision-making in China and Singapore - expert discussion

Prof Kurt Miller, Dr Li-qun Zhou and Dr Ravindran Kanesvaran
Cost constraints affect treatment decision-making in China and Singapore - expert discussion ( Prof Kurt Miller, Dr Li-qun Zhou and Dr Ravindran Kanesvaran )
21 Mar 2014

Insights into mCRPC in China, Thailand and Indonesia - expert discussion

Prof Rainy Umbas, Prof Narin Voravud and Prof Li Ping Xie
Insights into mCRPC in China, Thailand and Indonesia - expert discussion ( Prof Rainy Umbas, Prof Narin Voravud and Prof Li Ping Xie )
21 Mar 2014

The future of mCRPC treatment - expert discussion

Prof Li Ping Xie - Zhejiang University School of Medicine, Hangzhou, China and Prof Paul de Souza - University of Western Sydney, Sydney, Australia
The future of mCRPC treatment - expert discussion ( Prof Li Ping Xie - Zhejiang University School of Medicine, Hangzhou, China and Prof Paul de Souza - University of Western Sydney, Sydney, Australia )
21 Mar 2014

Sharing Indian perspectives on CRPC

Dr Senthil Rajippa - Kidwai Memorial Institute of Oncology, Bangalore, India
Sharing Indian perspectives on CRPC ( Dr Senthil Rajippa - Kidwai Memorial Institute of Oncology, Bangalore, India )
21 Mar 2014

PSA as a marker of disease in patients with prostate cancer and bone metastases

Prof Laurence Koltz, Prof Wolfgang Horninger, Prof Bertrand Tombal
PSA as a marker of disease in patients with prostate cancer and bone metastases ( Prof Laurence Koltz, Prof Wolfgang Horninger, Prof Bertrand Tombal )
28 Feb 2014

Impact of the cost of cancer care on Europe

Prof Richard Sullivan - King's College London, London, UK
Impact of the cost of cancer care on Europe ( Prof Richard Sullivan - King's College London, London, UK )
2 Feb 2014

ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic bone metastases

Dr Sten Nilsson - Karolinska University Hospital, Stockholm, Sweden
ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic bone metastases ( Dr Sten Nilsson - Karolinska University Hospital, Stockholm, Sweden )
1 Feb 2014

Predictive power of PSA patterns during off-time treatment periods with intermittent androgen deprivation

Dr Rafael Sanchez-Salas - Institut Mutualiste Montsouris, Paris, France
Predictive power of PSA patterns during off-time treatment periods with intermittent androgen deprivation ( Dr Rafael Sanchez-Salas - Institut Mutualiste Montsouris, Paris, France )
1 Feb 2014

Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer

Dr Tomasz M. Beer - Oregon Health & Science University, Portland, USA
Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer ( Dr Tomasz M. Beer - Oregon Health & Science University, Portland, USA )
31 Jan 2014

MET variant as a prognostic marker in clear cell renal cell carcinoma

Dr Ari Hakimi - Memorial Sloan-Kettering Cancer Center, New York, USA
MET variant as a prognostic marker in clear cell renal cell carcinoma ( Dr Ari Hakimi - Memorial Sloan-Kettering Cancer Center, New York, USA )
31 Jan 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation